(Total Views: 552)
Posted On: 08/04/2020 3:29:41 PM
Post# of 72447
@ Pete - I agree with your analysis. As an IV, I see limited use of B as a prophylactic. I like the idea of an inhaler, but am concerned that we may have to start over with Phase 1 trials to get an inhaler approved. Then again, given the urgency of the need, an inhaler that could be used as a prophylactic treatment might be rushed through at “warp speed” on a very abbreviated trial schedule.
You said, “This prophylactic would have to be in a form that could be easily taken by all people on the go and that would seem to favor some form of nubelized (mist/inhaler) Brilacidin.
Anybody know if that type of delivery system would be that hard or take that long to formulate?
If Brilacidin could do that, the world may just be able to get back to a pretty good form of what it was like pre-CV19.
Read More: https://investorshangout.com/post/viewall?id=...z6UBAnxtEW
You said, “This prophylactic would have to be in a form that could be easily taken by all people on the go and that would seem to favor some form of nubelized (mist/inhaler) Brilacidin.
Anybody know if that type of delivery system would be that hard or take that long to formulate?
If Brilacidin could do that, the world may just be able to get back to a pretty good form of what it was like pre-CV19.
Read More: https://investorshangout.com/post/viewall?id=...z6UBAnxtEW
(4)
(0)
